Recombinant Human IFNG | Z100345

abm | Recombinant Human IFNG | Z100345

IFNG is produced mainly by T cells and natural killer cells activated by antigens, mitogens or alloantigens and by lymphocytes expressing the surface antigens CD4 and CD8. Receptors for IFNG are expressed on all types of human cells with the exception of mature erythrocytes. IFNG-receptor complexes are rapidly internalized by endocytosis. In addition to its antiviral and antiparasitic activities, IFNG also inhibits the proliferation of a number of normal and transformed cells. The growth inhibitory activities of IFNG are in fact, more pronounced than those of the other interferons. However, the main biological activity of IFNG appears to be immunomodulatory in contrast to the other interferons that are mainly antiviral.

Functions:

The ED50 was found to be ≤ 0.5ng/ml as determined by its ability to induce dose dependent proliferation in vascular smooth muscle cells.

Organism:

Human

Source:

E. coli

Alias:

IFN-gamma, Immune interferon, IFNG, type II interferon, T cell interferon, MAF
Recombinant Human Interferon-Gamma (IFNG)

Gene Symbol:

IFNG

Gene ID:

3458

Accession:

P01579

Formulation:

Lyophilized from a 0.2 μm filtered solution in sodium phosphate and NaCl (pH 8.0)

Solubility:

A quick spin of the vial followed by reconstitution in 20mM acetic acid not less than 0.1 mg/mL.

Appearance:

Lyophilized Powder

Molecular Weight (kDa):

17

Molecular Weight 2 (kDA):

N/A

Molecular Weight 3 (kDA):

N/A

Purity:

>95% as determined by SDS-PAGE

Concentration:

<1.0 EU/μg of recombinant protein as determined by the LAL method

Shipping Condition :

Ambient Temperature

Storage Condition:

The lyophilized protein is stable for at least one year from date of receipt at -70°C. Upon reconstitution, this cytokine can be stored in working aliquots at 2° - 8°C for one month, or at -20°C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles.